KR940018343A - 트리글리세라이드 - Google Patents

트리글리세라이드 Download PDF

Info

Publication number
KR940018343A
KR940018343A KR1019940001449A KR19940001449A KR940018343A KR 940018343 A KR940018343 A KR 940018343A KR 1019940001449 A KR1019940001449 A KR 1019940001449A KR 19940001449 A KR19940001449 A KR 19940001449A KR 940018343 A KR940018343 A KR 940018343A
Authority
KR
South Korea
Prior art keywords
acid
triglyceride
triglycerides
composition
iii
Prior art date
Application number
KR1019940001449A
Other languages
English (en)
Inventor
데이비드 프레데릭 호로빈
오스틴 맥모르디
메하르 싱 만쿠
필립 나울즈
Original Assignee
마르, 카트리오나 프란세스
스코티아 홀딩스 공공유한회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939301582A external-priority patent/GB9301582D0/en
Priority claimed from GB939301801A external-priority patent/GB9301801D0/en
Application filed by 마르, 카트리오나 프란세스, 스코티아 홀딩스 공공유한회사 filed Critical 마르, 카트리오나 프란세스
Publication of KR940018343A publication Critical patent/KR940018343A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Cosmetics (AREA)

Abstract

영양과 의약에 유용한, 5-불포화 필수 지방산들과 올레산으로부터 선택된 적어도 두개의 서로 다른 산들을 갖는 트리글리세라이드.

Description

트리글리세라이드
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. a) ⅰ)GLA 및 DGLA, ⅱ)AA, 아드렌산 및 22:5n-6 산, ⅲ)스테아리돈산 및 20:4n-3 산, ⅳ)EPA, 22:5n-3 산 및 DHA, 올레산과 표 1의 산들의 상기 군들로부터 선택된 하나의 산의 두 잔기와 이와는 다르게 선택된 하나의 산의 한 잔기; 또는 b)올레산과 상기 ⅰ)~ⅳ)군의 산들로부터 선택된 산의 한 잔기, 이와는 다르게 선택된 산의 한 잔기 및 이와는 또 다르게 선택된 산의 한 잔기(단, 하나의 산이 한 군으로부터 선택될 때, 계속적인 선택은 동일한 군으로부터 하지 않는다)를 포함하는, 이성체들의 군으로서의 또는 단일한 트리글리세라이드.
  2. 제 1 항에 있어서, 참고번호 TG1~TG30중 임의의 하나로 표 4에 주어진 바와 같이 선택된 산 잔기들을 포함하는 트리글리세라이드.
  3. 제 1 항 또는 제 2 항에 있어서, 선택된 잔기들에 상응하는 종류와 비율의 물질로 출발하여 산과 글리세롤의 반응에 의해 제조된, 다른 트리글리세라이드와의 혼합물 형태의 트리글리세라이드.
  4. 제 3 항에 있어서, 제 1 항 또는 제 2 항에 따른 트리글리세라이드가 혼합물의 10보다 큰, 바람직하게는 30보다 큰, 더욱 바람직하게는 70보다 큰, 이상적으로는 90보다 큰 몰%를 구성하는 트리글리세라이드.
  5. 제 1 항 내지 제 4 항중 어느 한 항에 있어서, 일반적으로 제약학적 조성물 형태인 트리글리세라이드.
  6. 제 1 항 내지 제 4 항중 어느 한 항에 있어서, 영양공급원 또는 식품조성물 형태인 트리글리세라이드.
  7. 제 1 항 내지 제 4 항중 어느 한 항에 있어서, 국부용 제약, 피부 보호 또는 화장 조성물 형태인 트리글리세라이드.
  8. 제 5 항, 제 6 항 또는 제 7 항에 있어서, 조성물이 제 1 항 또는 제 2 항에 따른 트리글리세라이드 1mg~100g, 바람직하게는 10mg~10g, 매우 바람직하게는 500mg~4g의 일일 투여량을 제공하는 형태인 트리글리세라이드.
  9. 제 5 항, 제 6 항 또는 제 7 항에 있어서, 조성물이 제 1 항 또는 제 2 항에 따른 트리글리세라이드를 0.001~50중량%, 바람직하게는 0.05~20중량%, 매우 바람직하게는 0.1~5중량%를 포함하는 트리글리세라이드.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940001449A 1993-01-27 1994-01-27 트리글리세라이드 KR940018343A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939301582A GB9301582D0 (en) 1993-01-27 1993-01-27 Triglycerides
GB9301582.4 1993-01-27
GB939301801A GB9301801D0 (en) 1993-01-29 1993-01-29 Triglycerides
GB9301801.8 1993-01-29

Publications (1)

Publication Number Publication Date
KR940018343A true KR940018343A (ko) 1994-08-16

Family

ID=26302346

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019940001450A KR940018090A (ko) 1993-01-27 1994-01-27 트리글리세라이드
KR1019940001449A KR940018343A (ko) 1993-01-27 1994-01-27 트리글리세라이드

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019940001450A KR940018090A (ko) 1993-01-27 1994-01-27 트리글리세라이드

Country Status (11)

Country Link
US (2) US5670540A (ko)
EP (2) EP0611569A3 (ko)
JP (2) JPH07179398A (ko)
KR (2) KR940018090A (ko)
CN (2) CN1105016A (ko)
AU (2) AU673700B2 (ko)
CA (2) CA2114421A1 (ko)
MY (1) MY112705A (ko)
NO (2) NO940276L (ko)
NZ (2) NZ250727A (ko)
SG (2) SG49190A1 (ko)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9423625D0 (en) * 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
DE69613273T2 (de) * 1995-04-28 2001-10-31 Loders Croklaan Bv An polyungesättigten Fettsäuren reiche Triglyceride
EP0739590B1 (en) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
EP0739589B1 (en) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycerides, rich in Polyunsaturated fatty acids
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
EP0739591B1 (en) * 1995-04-28 2001-06-13 Loders Croklaan B.V. Triglycerides rich in polyunsaturated fatty acids
ATE201961T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
EP0823897B1 (en) * 1995-05-01 2004-07-28 Scarista Limited Nicotinic acid esters and pharmaceutical compositions containing them
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
AU2623797A (en) * 1995-12-11 1997-07-03 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9606216D0 (en) * 1996-03-25 1996-05-29 Scotia Holdings Plc Polyethylene glycol esters of fatty acids
EP2251412A3 (en) * 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
WO1997046219A1 (en) * 1996-06-03 1997-12-11 Croda International Plc Compositions and uses thereof
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
JP4062639B2 (ja) * 1996-12-23 2008-03-19 日本水産株式会社 皮膚外用剤
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
CA2313626A1 (en) * 1997-12-12 1999-06-17 Purdue Research Foundation Methods and compositions for treating diabetes
US6013665A (en) * 1997-12-16 2000-01-11 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US6136795A (en) * 1998-11-18 2000-10-24 Omni Nutraceuticals, Inc Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9901808D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Drugs for treatment of psychiatric and brain disorders
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
WO2001078531A2 (en) * 2000-04-18 2001-10-25 Natural As Conjugated linoleic acid powder
WO2002069964A1 (en) 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
JP2003048831A (ja) * 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
JP4791662B2 (ja) * 2001-09-30 2011-10-12 大和ハウス工業株式会社 断熱基礎を採用する建物における床下収納構造
US6652774B2 (en) * 2001-12-20 2003-11-25 Ferro Corporation Glycerin triester plasticizer
CN101837139B (zh) 2002-06-19 2014-05-28 帝斯曼知识产权资产管理有限公司 微生物油
AU2003267818B2 (en) * 2002-09-24 2009-12-17 Suntory Holdings Limited Composition containing arachidonic acid alone or in combination with docosahexaenoic acid for enhancing cognitive abilities
US7041840B2 (en) * 2002-12-18 2006-05-09 Alberta Research Council Inc. Antioxidant triacylglycerols and lipid compositions
CN1816287A (zh) * 2003-01-31 2006-08-09 宝洁公司 改善哺乳动物角质组织外观的方法
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
JP4522075B2 (ja) * 2003-10-29 2010-08-11 サントリーホールディングス株式会社 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP2006083136A (ja) * 2004-09-17 2006-03-30 Suntory Ltd ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
GB0425658D0 (en) * 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
KR100693150B1 (ko) 2005-04-06 2007-03-13 주식회사 리포젠 재구성된 트리글리세라이드 지질을 포함하는 식품 보충물조성물
JP5697293B2 (ja) * 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
JP5967855B2 (ja) * 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
PL2026828T3 (pl) 2006-06-08 2015-11-30 Iams Europe B V Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu
US8003813B2 (en) 2006-06-27 2011-08-23 Pos Pilot Plant Corporation Process for separating saturated and unsaturated fatty acids
KR101430214B1 (ko) 2006-12-28 2014-08-18 산토리 홀딩스 가부시키가이샤 신경 재생제
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EP2211881A4 (en) * 2007-11-01 2012-01-04 Wake Forest University School Of Medicine COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AFFECTING MAMMALS
JP5428107B2 (ja) * 2007-11-27 2014-02-26 出光興産株式会社 扁平上皮癌細胞増殖抑制剤
WO2009099886A1 (en) * 2008-01-31 2009-08-13 Monsanto Technology Llc Methods of improving dha deposition and related function and/or development
EP2095834B1 (de) * 2008-02-21 2015-07-01 Semperit Aktiengesellschaft Holding Prophylaxeartikel
FR2940281B1 (fr) * 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
US20110217370A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen
JPWO2012153832A1 (ja) * 2011-05-12 2014-07-31 日本水産株式会社 炎症性疾患用皮膚外用組成物
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
CN105793432B (zh) 2013-12-04 2022-02-25 日本水产株式会社 微生物油、微生物油的制造方法、浓缩微生物油及浓缩微生物油的制造方法
RU2714323C2 (ru) * 2014-06-04 2020-02-14 ДиЭс БАЙОФАРМА ЛИМИТЕД Фармацевтические композиции, содержащие дглк, и их применение
CN108025181A (zh) 2015-07-21 2018-05-11 艾菲穆恩有限公司 用于治疗或预防癌症和神经疾病的包括15-hepe的组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
JPS60222419A (ja) * 1984-04-17 1985-11-07 Terumo Corp 脂肪輸液剤
US4847296A (en) * 1984-09-13 1989-07-11 Babayan Vigen K Triglyceride preparations for the prevention of catabolism
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
US5151291A (en) * 1985-12-27 1992-09-29 Nisshin Flour Milling Co., Ltd. Glycerides of eicosapentaenoic acid, processes for preparing the same and oil and fat products containing the same
US5246726A (en) * 1986-03-21 1993-09-21 Efamol Ltd. Iron-containing composition and method for treatment of cancer
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention
JPS6416564A (en) * 1987-07-10 1989-01-20 Chisso Corp Composition for food additive
JPH0216988A (ja) * 1988-07-04 1990-01-19 Idemitsu Petrochem Co Ltd 濃縮された長鎖高度不飽和脂肪酸グリセリドの製造方法
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
WO1994010125A1 (en) * 1992-10-27 1994-05-11 Sandoz Ltd. Glycerin derivatives and uses thereof

Also Published As

Publication number Publication date
JPH07126160A (ja) 1995-05-16
EP0611569A3 (en) 1997-07-30
CN1105016A (zh) 1995-07-12
CA2114422A1 (en) 1994-07-28
NO940277D0 (no) 1994-01-26
EP0609001A3 (en) 1994-11-02
AU683027B2 (en) 1997-10-30
AU5382094A (en) 1994-08-04
NO940276D0 (no) 1994-01-26
NO940276L (no) 1994-07-28
SG49810A1 (en) 1998-06-15
EP0609001A2 (en) 1994-08-03
CN1104497A (zh) 1995-07-05
US5866703A (en) 1999-02-02
EP0611569A2 (en) 1994-08-24
KR940018090A (ko) 1994-08-16
CA2114421A1 (en) 1994-07-28
NZ250728A (en) 1996-01-26
NZ250727A (en) 1996-01-26
US5670540A (en) 1997-09-23
JPH07179398A (ja) 1995-07-18
NO940277L (no) 1994-07-28
AU673700B2 (en) 1996-11-21
MY112705A (en) 2001-08-30
SG49190A1 (en) 1998-05-18
AU5382194A (en) 1994-08-04

Similar Documents

Publication Publication Date Title
KR940018343A (ko) 트리글리세라이드
CA2175842A1 (en) Transesterified corn oil products
KR940018091A (ko) 불포화 지방산을 포함하는 처방
EP1961312A3 (en) Microbial oil mixture and uses thereof
AU2876289A (en) Salad/cooking oil balanced for health benefits
KR890000085A (ko) 필수지방산 합성물(Essential Fatty Acid Compositions)
RU94029679A (ru) Липидный состав для пищевых продуктов, способ его получения, пищевой продукт на его основе
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
ATE142435T1 (de) Nahrhafte zusammensetzung
KR940021057A (ko) 흡연의 악영향을 완화시키기 위한 조성물
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
EP1135991A3 (en) Oil composition and use thereof
DE69106561D1 (de) Oel-/Fett-Zusammensetzung.
ES2014060A6 (es) Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.
ES2171535T3 (es) Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
KR880007069A (ko) 트리글리세라이드 조성물
CA2405819A1 (en) Conjugated linoleic acid powder
MY131459A (en) Anti-bloom triglyceride compositions
KR910000157A (ko) 흡수성이 개선된 비타민 e 조성물
BG102234A (en) Esters of iodized fatty acids, the iodized fatty acids and their derivatives produced by the the addition of hydrogen iodide in the application of alkylylated derivatives and alkaline iodides, and their pharmacological application
CA2101246A1 (en) Polyose/fatty acid complex product with a high fatty acid content, use as an emulsifier or moisturizer and emulsifying or moisturizing composition in which it is present
CA2079889A1 (en) Solid, nondigestible, fat-like compounds and food compositions
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
NZ304924A (en) hybridised triglycerides
MY110558A (en) Patty acid salts and esters derived from palm oil, and soap compositions containing same.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid